Spectral AI Inc (NASDAQ:MDAI) announced its finance chief Peter M. Carlson will be stepping up to the role of CEO and has been appointed a member of the board.
The company highlighted that Carlson is an accomplished executive with a strong record of driving growth and operating and financial excellence at numerous public companies.
He has previously served as CFO of wound care innovator MiMedx Group and chief operating officer at MetLife spin-off company Brighthouse Financial.
He joined Spectral AI in January 2024 after the company debuted on the Nasdaq Global Market.
“In his short time here, Pete has already distinguished himself as a skilled and experienced leader and a tremendous asset to Spectral AI,” chairman of the Board of Directors Richard Cotton said in a statement.
“We are confident he is the right person to guide Spectral AI as we evolve from a late-stage development company and commercialize our revolutionary, AI-driven wound care technology.”
Carlson, meanwhile, commented: “I look forward to building on the team’s impressive work to date and lending my experience to ensure we establish the operating and financial foundation that is necessary to deliver on Spectral AI’s full potential.”
Carlson takes over the position from Wensheng Fan who, after 14 years with the company, is transitioning to Chief Innovation Strategist and Senior Advisor to the CEO.
“Pete is the right person to serve as CEO as we progress from R&D to commercialization, and I look forward to supporting Pete as an advisor while I continue my focus on Spectral AI’s innovation,” Fan said in a statement.
Spectral AI’s General Counsel and Corporate Secretary Vincent S. Capone will take on the additional role of CFO.
Dallas, Texas-based Spectral AI is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers.